套住了 止损查看全文
牛唐2020-06-19 14:01
生物医药领域成为疫情期间IPO的亮点,在过去两个月里,包括$Lyra Therapeutics(LYRA)$ 在内,有4家上市公司都属于生物医药的范畴,包括$ORIC制药(ORIC)$ ,$Keros(KROS)$ ,以及Zentalis Pharmaceuticals。这些生物医药公司不仅顺利IPO,而且平均回报率达82%查看全文
$Lyra Therapeutics(LYRA)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-20-329939 Act: 34 Size: 115 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-034285 Size: 4 KB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K/A [Amend] Current report, item 5.02 Accession Number: 0001193125-20-314971 Act: 34 Size: 17 KB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001193125-20-311233 Act: 34 Size: 180 KB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-20-053015 Act: 34 Size: 493 KB 网页链接
$Lyra Therapeutics(LYRA)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-20-053016 Act: 34 Size: 6 MB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, item 5.02 Accession Number: 0001193125-20-282679 Act: 34 Size: 17 KB 网页链接
$Lyra Therapeutics(LYRA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-029782 Size: 5 KB 网页链接
$Lyra Therapeutics(LYRA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000899243-20-029768 Size: 7 KB 网页链接
$Lyra Therapeutics(LYRA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-20-036787 Act: 34 Size: 493 KB 网页链接